Костик Михаил Михайлович, доктор мед. наук, профессор
Кафедра госпитальной педиатрии ФГБОУ ВО «Санкт-Петербургский государственный педиатрический медицинский университет» Минздрава России
Санкт-Петербург, Литовская ул., 2
Занимаемые должности в разные годы
С 2000 г. по настоящее время – кафедра госпитальной педиатрии ФГБОУ ВО «Санкт-Петербургский государственный педиатрический медицинский университет» Минздрава России (ассистент, доцент, профессор);
2019 г. – по настоящее время – главный внештатный специалист ревматолог детский комитета по здравоохранению администрации г. Санкт-Петербурга;
2019 г. – по настоящее время – главный внештатный специалист ревматолог детский Северо-Западного Федерального округа Российской Федерации
Список статей в иностранных журналах:
1. Kostik MM, Klyushina AA, Moskalenko MV, et al. Glucocorticoid receptor gene polymorphism and juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2011 Jan 13;9(1):2. doi: 10.1186/1546-0096-9-2.
2. Papadopoulou C, Kostik M, Gonzalez-Fernandez MI, et al. Delineating the role of multiple intra- articular corticosteroid injections in the management of juvenile idiopathic arthritis in the biologic era. Arthritis Care Res (Hoboken). 2013 Jul;65(7):1112-20. doi: 10.1002/acr.21947.
3. Kostik MM, Chikova IA, Avramenko VV, et al. Farber lipogranulomatosis with predominant joint involvement mimicking juvenile idiopathic arthritis. J Inherit Metab Dis. 2013 Nov;36(6):1079-80. doi: 10.1007/s10545-012-9573-z.
4. Snegireva LS, Kostik MM, Caroli F, et al. Failure of tocilizumab treatment in a CINCA patient: clinical and pathogenic implications. Rheumatology (Oxford). 2013;52(9):1731-2. doi: 10.1093/rheumatology/ket121.
5. Papadopoulou C, Kostik M, Böhm M, et al. Methotrexate Therapy May Prevent the Onset of Uveitis in Juvenile Idiopathic Arthritis. J Pediatr. 2013 Sep;163(3):879-84. doi: 10.1016/j.jpeds.2013.03.047. Epub 2013 May 9.
6. Kostik MM, Smirnov AM, Demin GS, et al. Genetic polymorphisms of collagen type I α1 chain (COL1A1) gene increase the frequency of low bone mineral density in the subgroup of children with juvenile idiopathic arthritis. EPMA J. 2013 Jun 13;4(1):15. doi: 10.1186/1878-5085-4-15.
7. Kostik MM, ChikovaIA, Solovyev AA, et al. The Initial Effectiveness of Rituximab for Nephrotic Syndrome in Severe Pediatric Henoch-Schonlein Glomerulonephritis. Ann Paediatr Rheum. 2013;2(3):124-7. doi:10.5455/apr.082920130003
8. Zernyuk AD, Cutusheva GF, Kostik MM, Masalova VV. Analysis of Menstrual Dysfunction in Girls Suffering from Juvenile Idiopathic Arthritis. International Journal of BioMedicine. 2013;3(4):274-8
9. Kostik MM, Smirnov AM, Demin GS, et al. Juvenile idiopathic arthritis patients and their skeletal status: possible role of vitamin D receptor gene polymorphism. Mol Biol Rep. 2014;41(4):1937-43. doi: 10.1007/s11033-014-3040-x. Epub 2014 Jan 12.
10. Chasnyk V, Fedorova E, Egorov A, et al. Is the CCR5-delta32 Mutation Protective Against Systemic-Onset Juvenile Idiopathic Arthritis? Arthritis Rheumatol. 2014 Mar;66 Suppl 3:S171. doi: 10.1002/art.38551.
11. Kostik MM, Kuzmina DA, Novikova VP, et al. Caries in adolescents in relation to their skeletal status. J Pediatr Endocrinol Metab. 2015 Mar;28(3-4):399-405. doi: 10.1515/jpem-2014-0165.
12. Kostik MM, Dubko MF, Masalova VV, et al. Identification of the best cut-off points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis. Semin Arthritis Rheum. 2015 Feb;44(4):417-22. doi: 10.1016/j.semarthrit.2014.09.004. Epub 2014 Sep 11.
14. Cabral DA, Canter DL, Muscal E, et al; ARChiVe Investigators Network within the PedVas initiative. Comparing presenting clinical features of 48 children with microscopic polyangiitis (MPA) against 183 having granulomatosis with polyangiitis (GPA). An ARChiVe study. Arthritis Rheumatol. 2016 Oct;68(10):2514-26. doi: 10.1002/art.39729.
15. Kostik MM, Gaidar EV, Hynnes AY, et al. Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use. Clin Exp Rheumatol. 2016 Jul-Aug;34(4):714-8. Epub 2016 Jun 22.
16. Morishita KA, Moorthy LN, Lubieniecka JM, et al; ARChiVe Investigators Network within the PedVas Initiative. Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2017 Jul;69(7):1470-1479. doi: 10.1002/art.40112. Epub 2017 Jun 9.
17. Schulert GS, Minoia F, Bohnsack J, et al. Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis. Arthritis Care Res (Hoboken). 2018 Mar;70(3):409-419. doi: 10.1002/acr.23277.
18. Kostik MM, Isupova EA, ChikovaIA, et al. Reasons for inactive disease and flare in systemic onset juvenile idiopathic arthritis patients during tocilizumab treatment. Clin Exp Rheumatol. 2018 Mar-Apr;36(2):335-341. Epub 2017 Dec 15.
19. Kostik MM, Suspitsin EN, Guseva MN, et al. Multigene sequencing reveals heterogeneity of NLRP12-related autoinflammatory disorders. Rheumatol Int. 2018;38(5):887-893. doi: 10.1007/s00296-018-4002-8.
20. Kostik MM, Kopchak OL, ChikovaIA, et al. Comparison of different treatment approaches of pediatric chronic non-bacterial osteomyelitis. Rheumatol Int. 2019 Jan;39(1):89-96. doi: 10.1007/s00296-018-4151-9. Epub 2018 Aug 31.
21. Foeldvari I, Klotsche J,TorokKS, et al. Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort. Journal of Scleroderma and Related Disorders 1-13, 2018.
22. Kostik MM, Kopchak OL, Maletin AS, Mushkin AY. The peculiarities and treatment outcomes of the spinal form of chronic non-bacterial osteomyelitis in children: a retrospective cohort study. Rheumatol Int. 2019 Nov 21. doi: 10.1007/s00296-019-04479-2. [Epub ahead of print]
